Financial giants have made a conspicuous bullish move on Eli Lilly ( LLY ). Our analysis of options history for Eli Lilly ( LLY ) revealed 13 unusual trades.
Delving into the details, we found 23% of traders were bullish, while 15% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $609,596, and 4 were calls, valued at $150,651.
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $300.0 to $900.0 for Eli Lilly ( LLY ) over the recent three months.
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly's ( LLY ) options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's ( LLY ) whale trades within a strike price range from $300.0 to $900.0 in the last 30 days.
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | PUT | SWEEP | NEUTRAL | 686 | 379 | ||||||
| LLY | PUT | SWEEP | NEUTRAL | 1.3K | 553 | ||||||
| LLY | PUT | TRADE | NEUTRAL | 196 | 7 | ||||||
| LLY | PUT | SWEEP | BULLISH | 364 | 38 | ||||||
| LLY | CALL | TRADE | NEUTRAL | 53 | 1 |
Eli Lilly ( LLY ) is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
In light of the recent options history for Eli Lilly ( LLY ), it's now appropriate to focus on the company itself. We aim to explore its current performance.
Currently trading with a volume of 1,003,032, the LLY's price is down by -3.48%, now at $757.73.
RSI readings suggest the stock is currently may be approaching overbought.
Anticipated earnings release is in 48 days.
In the last month, 1 experts released ratings on this stock with an average target price of $936.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
* An analyst from Guggenheim has revised its rating downward to Buy, adjusting the price target to $936.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly ( LLY ) options trades with real-time alerts from Benzinga Pro.
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
